Ramos, M.; Quezada-Feijoó, M.; Ayala, R.; Manzano, A.; Gómez-Pavón, F.J.; Jaramillo, J.; Herrera, C.; López Vazquez de la Torre, M.; Toro, R.
Value of NT-proBNP and Galectin-3 as Biomarkers in the Follow-Up of Asymptomatic Elderly Patients with Severe Aortic Stenosis. J. Clin. Med. 2023, 12, 2987.
https://doi.org/10.3390/jcm12082987
AMA Style
Ramos M, Quezada-Feijoó M, Ayala R, Manzano A, Gómez-Pavón FJ, Jaramillo J, Herrera C, López Vazquez de la Torre M, Toro R.
Value of NT-proBNP and Galectin-3 as Biomarkers in the Follow-Up of Asymptomatic Elderly Patients with Severe Aortic Stenosis. Journal of Clinical Medicine. 2023; 12(8):2987.
https://doi.org/10.3390/jcm12082987
Chicago/Turabian Style
Ramos, Mónica, Maribel Quezada-Feijoó, RocÃo Ayala, Ascensión Manzano, Francisco Javier Gómez-Pavón, Javier Jaramillo, Cristina Herrera, Mariola López Vazquez de la Torre, and RocÃo Toro.
2023. "Value of NT-proBNP and Galectin-3 as Biomarkers in the Follow-Up of Asymptomatic Elderly Patients with Severe Aortic Stenosis" Journal of Clinical Medicine 12, no. 8: 2987.
https://doi.org/10.3390/jcm12082987
APA Style
Ramos, M., Quezada-Feijoó, M., Ayala, R., Manzano, A., Gómez-Pavón, F. J., Jaramillo, J., Herrera, C., López Vazquez de la Torre, M., & Toro, R.
(2023). Value of NT-proBNP and Galectin-3 as Biomarkers in the Follow-Up of Asymptomatic Elderly Patients with Severe Aortic Stenosis. Journal of Clinical Medicine, 12(8), 2987.
https://doi.org/10.3390/jcm12082987